CJC-1295 w/o DAC
CJC-1295 without DAC (Modified GRF 1-29) is a synthetic 29-amino acid modified analog of GHRH incorporating four amino acid substitutions to enhance enzymatic stability while maintaining targeted GHRH receptor binding without albumin conjugation. Supplied as a lyophilized powder in a 3mL vial, it is intended exclusively for in vitro laboratory research by qualified scientific personnel.
This peptide has been utilized in preclinical studies examining GHRH receptor binding kinetics, pulsatile pituitary somatotroph signaling dynamics, GH secretion pathway activity, and short-duration receptor interaction profiles — independent of the broader endocrine effects associated with endogenous GHRH activity.
Product Details
- Form: Lyophilized powder (for laboratory research)
- Amount: 5 mg or 10 mg per vial
- Purity: ≥ 98% (HPLC tested)
- Sequence: Modified GHRH (30 amino acids, no DAC modification)
- Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
- Molecular Weight: ~3367 Da
- Intended Use: Laboratory research only
DISCLAIMER: This product is strictly to be used for scientific research use only. It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes.
We recommend you review our Terms of Service if you have questions about product use.
